SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Natsume Sōseki — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientNatsume Sōseki
Date of birth1867-02-09
IdentifiersMRN HR-ET023-SYN-TD; SSN (made up) 000-23-8840
Document date1910-06-04
AuthorHaruka Lindqvist-Mori, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review: biopsy results, resistance testing, and eradication therapy. [S]

History of Present Illness

Mr. Natsume returns two weeks after his endoscopy. The epigastric pain stopped within four days of starting vonoprazan, and he now sleeps through the night. His stools are dark and formed on iron, with no sticky, tarry stools; he has not vomited or felt faint. He takes the iron every other morning without stomach upset. He has taken no NSAIDs. He is writing his serial again each morning and eats at more regular hours. [S]

ElementDetail
PainGone within four days of vonoprazan
StoolsDark and formed on iron; no tarry stools
MedicinesVonoprazan 20 mg each morning; ferrous sulfate every other morning; no NSAIDs

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy a little better; no fever
GastrointestinalNegativeNo epigastric pain, vomiting, or tarry stools; dark formed stools on iron
CardiovascularNegativeNo lightheadedness
IntegumentaryNegativeNo rash

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen)One or two tablets every six hours as needed; no more than six tablets a dayOral route1910-05-18activeS
Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healingOne tablet each morning for eight weeksOral route1910-05-21 to 1910-07-16completedS
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other dayOne tablet every other morningOral route1910-05-21activeS
Vonoprazan 20 mg oral tablet, one extra tablet by mouth each evening for 14 days during eradication therapy (20 mg twice daily with the morning dose)One tablet each evening for 14 daysOral route1910-06-04 to 1910-06-17completedS
Amoxicillin 500 mg oral capsule, two capsules (1 g) by mouth three times daily for 14 daysTwo capsules three times daily for 14 daysOral route1910-06-04 to 1910-06-17completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1910-06-04Body height159cmS
1910-06-04Body weight52.2kgS
1910-06-04Body mass index (BMI) [Ratio]20.6kg/m2S
1910-06-04Systolic blood pressure120mm[Hg]S
1910-06-04Diastolic blood pressure76mm[Hg]S
1910-06-04Heart rate78/minS
1910-06-04Respiratory rate14/minS
1910-06-04Body temperature36.6CelS
1910-06-04Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1910-06-04Hemoglobin [Mass/volume] in Blood11.8g/dL13.2-17.1 g/dLLowS

Physical Exam

Vital signs recorded on 1910-06-04; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 52.2 kg; pulse 78, blood pressure 120/76
AbdomenSoft and non-tender
ConjunctivaeSlightly pale

Problems

ProblemClinical statusVerificationCodeProvenance
About three weeks of gnawing epigastric pain, worse before meals and at night and eased by food, with two episodes of black, tarry stools ten days ago and iron-deficiency anemia; stable, Glasgow-Blatchford score 4; peptic ulcer suspected and urgent endoscopy bookedresolvedconfirmed R10.13S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its timing echoes his documented stomach illness of May 1910 (D).
Gastric ulcer, 15 mm, on the lesser curvature at the angulus, with recent bleeding (melena) and a clean base at endoscopy (Forrest III); margin biopsies benign; Helicobacter pylori positive; synthetic modern diagnosis for his documented gastric ulceractiveconfirmed K25.4S — Synthetic modern diagnosis anchored to his documented gastric ulcer (D); the Helicobacter pylori cause is synthetic.
Helicobacter pylori infection (rapid urease test and histology positive; clarithromycin resistance mutation on biopsy PCR)activeconfirmed B96.81S — Synthetic finding at endoscopy; no historical claim is made about the organism in his illness.
Iron-deficiency anemia from chronic blood loss (hemoglobin 11.2 g/dL, MCV 76 fL, ferritin 8 ng/mL)activeconfirmed D50.0S — Synthetic finding at intake.
Chronic atrophic gastritis from Helicobacter pylori, moderate atrophy with focal intestinal metaplasia in the antrum (OLGA stage II, OLIM stage I; open-type endoscopic atrophy); no dysplasia; yearly endoscopic surveillanceactiveconfirmed K29.40S — Synthetic histology finding at the two-week visit; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryUpper endoscopy with biopsy of the ulcer marginAt diagnosis; repeat for a gastric ulcer at 8 to 12 weeks to confirm healing and biopsy the scarCompleted todayMargin biopsies benign; no dysplasia or cancer; repeat endoscopy at about ten weeks
LaboratoryHelicobacter pylori test (rapid urease test and histology) with clarithromycin-resistance testingAt diagnosisCompleted todayHistology positive; clarithromycin-resistance mutation on PCR
Medication safetyEradication therapy: adherence and side effectsAt the start and during the courseCompleted todayVonoprazan-amoxicillin dual therapy for 14 days started today; adherence and side effects explained
LaboratoryTest of eradication (13C urea breath test)At least four weeks after antibiotics and two weeks after acid suppressionDueAbout seven weeks after the course ends
Medication safetyAcid suppression for ulcer healing (vonoprazan)Daily for eight weeks for a gastric ulcerCompleted todayTaking vonoprazan each morning; pain gone
Medication safetyNSAID avoidanceEvery visitCompleted todayNone taken
Self-managementBleeding warning signs and when to call 119Every visitCompleted todayNo tarry stools or vomiting; dark stools on iron explained
Self-managementAlcohol, smoking and mealsEvery visitCompleted todayMeals more regular; no smoking; less salt advised
LaboratoryBlood count on oral ironAbout four weeks after starting oral iron, then every three months for a year (CMID)Completed todayHemoglobin 11.8 g/dL two weeks after starting iron, up 0.8 g/dL; next at about four weeks
LaboratoryGastric cancer surveillance: atrophy and intestinal metaplasia stagingAt diagnosis, then endoscopy yearly after eradication when atrophy or intestinal metaplasia is presentCompleted todayOLGA stage II, OLIM stage I; open-type atrophy; no dysplasia: yearly surveillance

Goal progress:

Guideline basis: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024); Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022); Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition (2016 (published 2019)); Evidence-based clinical practice guidelines for peptic ulcer disease 2026 (2026); ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (2021); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)

Follow-up: Blood count in about four weeks. Eleven-week review in early August with the urea breath test, repeat endoscopy, blood count and ferritin. Call 119 for black, tarry stools, vomiting blood or fainting. Next scheduled visit 1910-06-16: periodic adult preventive visit. [S]